Cardiac mast cell stabilization and cardioprotective effect of ischemic preconditioning in isolated rat heart

Journal of Cardiovascular Pharmacology

Volumn 31, Issue 5, 1998, Pages 779-785

  Parikh, Vinay ^a   Singh, Manjeet ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

Cardioprotection; Ischemic preconditioning; Mast cell peroxidase

Indexed keywords

CREATINE KINASE; CROMOGLYCATE DISODIUM; LACTATE DEHYDROGENASE; PEROXIDASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; ISOLATED HEART; MAST CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-ASTHMATIC AGENTS; ARRHYTHMIA; CREATINE KINASE; CROMOLYN SODIUM; FEMALE; HEART; ISCHEMIC PRECONDITIONING, MYOCARDIAL; L-LACTATE DEHYDROGENASE; MAST CELLS; MYOCARDIUM; PEROXIDASE; RATS; RATS, WISTAR;

EID: 0031977639     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199805000-00018     Document Type: Article

References (29)

1. Chatelain P, Latour JG, Tran D, deLorgeril M, Dupras G, Bourassa M. Neutrophil accumulation in experimental myocardial infarcts: relation with extent of injury and effect of reperfusion. Circulation 1987;75:1083-90.
2. Mullane KM, Read N, Salmon JA, Moncada S. Role of leucocytes in acute myocardial infarction in anaesthetised dogs: relationship to myocardial salvage by anti-inflammatory drugs. J Pharmacol Exp Ther 1984;228:510-22.
3. Romson JL, Hook BG, Rigot VH, Schork MA, Swanson DP, Lucchesi BR. The effect of ibuprofen on accumulation of indium-111 labelled platelets and leukocytes in experimental myocardial infarction. Circulation 1982;66:1002-11.
4. Lucchesi BR, Mullane KM. Leukocytes and ischaemia induced myocardial injury. Annu Rev Pharmacol Toxicol 1986;26:201-4.
5. Pollak OJ. Mast cells in the circulatory system of man. Circulation 1957;16:1084-9.
6. Rydsynski K, Dalen H, Saetersdal T, Engedal H. Morphologic and morphometric analysis of the mast cells in human heart biopsies. Agents Actions 1987;20:288-9.
7. Keller AM, Clancy RM, Barr ML, Marbee CC, Cannon PJ. Acute reoxygenation injury in isolated rat heart: role of resident cardiac mast cells. Circ Res 1988;63:1044-52.
8. Ito BR, Engler RL, DelBalzo U. Role of cardiac mast cells in complement C-5a induced myocardial ischemia. Am J Physiol 1993;264:H1346-54.
9. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischaemia: a delay of lethal cell injury in ischaemic myocardium. Circulation 1986;74:1124-36.
10. 3 receptors: pharmacological properties, species differences and receptors functions. Trends Pharmacol Sci 1994;15:298-306.
11. Parratt JR. Possibilities for the pharmacological exploitation of ischaemic preconditioning. J Mol Cell Cardiol 1995;27:991-1000.
12. Parikh V, Singh M. Resident cardiac mast cells and cardioprotective effect of ischemic preconditioning in isolated rat heart. J Cardiovasc Pharmacol 1997;30:149-56.
13. + exchange inhibitor on cardioprotective effect of ischaemic preconditioning: possible involvement of resident cardiac mast cells. Pharmacol Res 1997;36:95-102.
14. Wang P, Downey JM, Cohen MV. Mast cell degranulation does not contribute to ischemic preconditioning in isolated rabbit hearts. Basic Res Cardiol 1996;91:458-67.
15. Langendorff O. Untersuchungen am uberlebender saugethierherzen. Pflugers Arch 1895;61:291-332.
16. Hughes BP. A method for the estimation of serum creatine kinase and aldose activity in the normal and pathological sera. Clin Chim Acta 1961;7:597-603.
17. King J. A routine method for the estimation of lactic dehydrogenase activity. J Med Lab Technol 1959;16:265-72.
18. Walker MJA, Curtis MJ, Hearse DJ, et al. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia, infarction and reperfusion. Cardiovasc Res 1988;22:447-55.
19. Fralix TA, Steenbergen C, London RE, Murphy E. Glibenclamide does not abolish the protective effect of preconditioning on stunning in the isolated perfused rat heart. Cardiovasc Res 1993;27:630-7.
20. Omar BA, Hanson AK, Bose SK, McCord JM. Reperfusion with pyruvate eliminates ischemic preconditioning in the isolated rabbit heart: an apparent role for enhanced glycolysis. Coron Artery Dis 1991;2:799-804.
21. Grover GJ, Dzwonczyk S, Sleph PG, Sargent CA. The ATP-sensitive potassium channel blocker glibenclamide (glyburide) does not abolish preconditioning in isolated ischemic rat hearts. J Pharmacol Exp Ther 1993;265:559-64.
22. Steenbergen C, Perlman ME, London RE, Murphy E. Mechanism of preconditioning: ionic alterations. Circ Res 1993;72:112-25.
23. Li Y, Whittaker P, Kloner RA. The transient nature of the effect of ischemic preconditioning on myocardial infarct size and ventricular arrhythmia. Am Heart J 1992;123:346-53.
24. Austen KF. The heterogeneity of mast cell populations and products. Hosp Pract 1984;19:135-46.
25. Hendeson WR, Kaliner M. Mast cell granule peroxidase: location, secretion and SRS-A activation. J Immunol 1979;122:1322-8.
26. Schwartz LB, Austen KF. Structure and function of chemical mediators of mast cells. Prog Allergy 1984;34:271-321.
27. Theoharides TC, Sieghart W, Cirengaard P, Douglas WW. An antiallergic drug cromolyn may inhibit histamine secretion by regulating phosphorylation of a mast cell protein. Science 1980;207:80-2.
28. Flint KC, Leung KBP, Pearce FL, Hudspith BN, Brostoff J, Johnson NM. Human mast cells recovered by bronchoalveolar lavage: their morphology, histamine release and the effects of sodium cromoglycate. Clin Sci 1985;68:427-32.
29. Jolly SR, Abrams GD, Romson JL, Bailie MB, Lucchesi BR. Effects of lodoxamide on ischemic reperfused myocardium. J Cardiovasc Pharmacol 1982;4:441-8.